Gene editing, AI and the medical advances of 2026
When results for a new pancreatic cancer pill were presented at the American Society of Clinical Oncology’s annual meeting in May, the audience gave them a rare, 42s standing ovation. It was one of a string of medical advances this year, several built on gene editing and AI, that have mostly stayed in the specialist…
